Inherited renal cancer.
Turner
K J
KJ
Imperial Cancer Research Fund, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK. turnerk@icrf.icnet.uk
D043925:Angiogenesis Inducing Agents / Q000235:genetics; D002292:Carcinoma, Renal Cell / Q000098:blood supply / Q000235:genetics*; D006801:Humans; D000860:Hypoxia / Q000235:genetics; D007680:Kidney Neoplasms / Q000098:blood supply / Q000235:genetics*; D008025:Ligases; D009154:Mutation / Q000235:genetics; D009389:Neovascularization, Pathologic; D010375:Pedigree; D011506:Proteins / Q000235:genetics / Q000502:physiology; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D009396:Wilms Tumor / Q000235:genetics / Q000628:therapy; D006623:von Hippel-Lindau Disease / Q000235:genetics
D043925:Angiogenesis Inducing Agents; D011506:Proteins; D025521:Tumor Suppressor Proteins; D044767:Ubiquitin-Protein Ligases; D051794:Von Hippel-Lindau Tumor Suppressor Protein; D008025:Ligases; C497446:VHL protein, human